FDA Drug Application (202361) for VORICONAZOLE by MYLAN PHARMS INC

Back to FDA Applications sponsored by MYLAN PHARMS INC

Application Number202361
Product Number001
FormFOR SUSPENSION;ORAL
Dosage200MG/5ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameVORICONAZOLE
Active IngredientVORICONAZOLE

Active IngredientCount
List of drugs with Active Ingredient VORICONAZOLE2


Back to FDA Applications sponsored by MYLAN PHARMS INC